PISCIVAC Irido Si

Category

Vaccine type

  • Inactivated water-based vaccine for intramuscular and intraperitoneal injections

Target Diseases

  • Iridoviral disease caused by infectious spleen and kidney necrosis virus (ISKNV)
  • Streptococcosis caused by Streptococcus iniae

Target Species

  • Asian seabass or barramundi

Key Features

  • Rapid protection within 3 dpv against ISKNV and S. iniae in Asian seabass
  • Long duration of protection against iridoviral disease and streptococcosis for at least 2 mpv and 11 mpv, respectively

Efficacy

Laboratory test Trial I

Pathogens

DPV RPS

ISKNV

21 76

S. iniae

32 78

Laboratory test Trial II

Pathogens

DPV RPS

ISKNV

3 89
7 85
14 79

S. iniae

3 89
7 97
14 100

Laboratory test Trial III

Pathogens

DPV RPS

ISKNV

28 90
74 75

S. iniae

102 90
348 88

DPV: days post-vaccination

RPS: relative percent survival

Add to quote

Vaccines available in the market

  • Vaccines for Streptococcus iniae bacteria infection and Iridovirus infection are sold separately.
  • Oil-based vaccine which the fish will take longer to dissipate.

Solutions from Kyoritsu

  • In order to tackle the 2 most common infections for Barramundi, a two-in-one vaccine has been developed in Piscivac Irido Si.
  • Having a two-in-one vaccine is more cost effective and more productive as the task of vaccinating the fish is made easier.
  • Kyoritus’s water-base vaccine can be easily absorbed by the fish.